Connect with us

Business Wire

WM Technology, Inc. Announces Second Quarter 2022 Financial Results Conference Call

Published

on


IRVINE, Calif.–(BUSINESS WIRE)–$MAPS #MAPS–WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), the leading marketplace and technology solutions provider to the cannabis industry, today announced it will report financial results for its second quarter ended June 30, 2022 after market close on Tuesday, August 9, 2022.

Management will host a conference call and webcast to discuss the Company’s financial results at 2:00 p.m. Pacific Time (or 5:00 p.m. Eastern Time) on the same day. Participants may register for the call here. A live webcast of the call will also be available on the WM Technology investor relations website at ir.weedmaps.com.

A replay of the Q2 call will be available at ir.weedmaps.com by end of day Aug. 10.

Call Details – WM Technology Second Quarter 2022 Financial Results:

About WM Technology

Founded in 2008, WM Technology operates the leading online cannabis marketplace, Weedmaps, with a comprehensive set of eCommerce and compliance software solutions, WM Business, sold to retailers and brands in the U.S. state-legal and Canadian cannabis markets. The Company’s mission is to power a transparent and inclusive global cannabis economy.

The Company’s technology addresses the challenges facing both consumers seeking to understand cannabis products and businesses who serve cannabis users in a legally compliant fashion. Over the past 14 years, the Weedmaps marketplace has become the premier destination for cannabis consumers to discover and browse information regarding cannabis and cannabis products, permitting product discovery and order-ahead for pickup or delivery by participating retailers. WM Business is a set of eCommerce-enablement tools designed to help retailers and brands get the best out of the Weedmaps’ consumer experience, create labor efficiencies, and manage compliance needs.

WM Technology holds a strong belief in the power of cannabis and the importance of enabling safe, legal access to consumers worldwide. Since inception, WM Technology has worked tirelessly, not only to become the most comprehensive platform for consumers, but to build the software solutions that power businesses compliantly in the space, to advocate for legalization, social equity, and licensing in many jurisdictions, and to facilitate further learning through partnering with subject matter experts on providing detailed, accurate information about the plant.

Headquartered in Irvine, California, WM Technology supports remote work for all eligible employees. Visit us at www.weedmaps.com.

Contacts

Media: Travis Rexroad, press@weedmaps.com
Investor Relations: investors@weedmaps.com

This post was originally published on this site





Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published.

Business Wire

WM Technology, Inc. Launches Weedmaps for Business, the Fully Integrated Suite of End-to-End SaaS Solutions for Cannabis Retailers and Brands

Published

on

By


IRVINE, Calif.–(BUSINESS WIRE)–$MAPS–WM Technology, Inc. (“WM Technology” or the “Company”) (Nasdaq: MAPS), the leading marketplace and technology solutions provider to the cannabis industry, today announced the launch of Weedmaps for Business. Formerly WM Business, the Company’s reconfiguration and renaming of its SaaS offerings better reflects the comprehensive B2B and B2C suite of products that affords cannabis retailers and brands of all sizes with fully integrated tools to run their businesses.


“Since 2008, we have been working to build a complete SaaS platform that provides a suite of compliant, data-driven solutions that enables our clients to reach, convert, and retain customers both online and in-store,” said Chris Beals, CEO of WM Technology. “While consumer discovery will always be the key value that we offer to our clients, the Weedmaps model has migrated naturally upstream to power and grow businesses holistically.”

This realignment includes the integration of WM Technology’s recent acquisitions — Sprout, Enlighten, Cannveya, and CannCurrent — and enables the technology company to provide an interconnected suite of logical, end-to-end solutions. With the addition of these companies, WM Technology now supports businesses at every stage in the consumer funnel which enables cannabis businesses to:

  • Strategically reach prospective cannabis customers through Weedmaps’ marketplace via WM Listings, WM Deals and WM Ads, and extend that reach through WM AdSuite.
  • Compliantly manage pick-up, delivery, and inventory in accordance with local regulations through WM Orders and WM Dispatch.
  • Help improve customer experience by creating online ordering functionality on a brand or retailer’s website with WM Store and extend that functionality in-store with kiosks from WM Screens.
  • Foster customer loyalty and re-engage consumers with WM CRM and its integration with the Weedmaps marketplace.
  • Leverage the Weedmaps for Business products in conjunction with any other preferred software solutions via our third party integrations and create a scalable customized workflow with WM Connectors.
  • Make informed marketing and merchandising decisions using performance analytics and consumer and brand insights to promote products to specific consumer groups with WM Insights.

According to Christopher Fenske, Chief Strategy Officer at California-based dispensary Jaderoom, the company has leveraged Weedmaps’ suite of tools to help enable growth from a single delivery operation to a vertically integrated brand in just under two years.

“The biggest hurdle in the cannabis industry right now is connecting all the software seamlessly between your CRM, orders fulfillment, and delivery management system, yet Weedmaps took this challenge head on,” Fenske said. “We started with Weedmaps because we knew the strength of their customer base, and as I look at what we’ve been able to build in less than two years, much of the credit for our success we attribute to Weedmaps.”

The newly structured business offerings from WM Technology are grounded in the company’s long standing industry experience and consumer insights, and are available by monthly subscription.

“Weedmaps was established fourteen years ago with the goal of making cannabis more accessible, and a large part of that is ensuring that cannabis businesses can effectively reach customers using data driven marketing and operational strategies,” said Beals. “We believe our product offerings will help cannabis retailers and brands reach valuable consumers, streamline and simplify their operations extremely efficiently, which is critical in current market conditions.”

To learn more about Weedmaps for Business and the Company’s suite of SaaS solutions, please visit: https://weedmaps.com/business/.

About WM Technology

Founded in 2008, WM Technology operates the leading online cannabis marketplace for consumers together with a comprehensive set of eCommerce and compliance software solutions for cannabis businesses, which are sold to retailers and brands in the U.S. state-legal and Canadian cannabis markets. The Company’s mission is to power a transparent and inclusive global cannabis economy.

The Company’s technology addresses the challenges facing both consumers seeking to understand cannabis products and businesses who serve cannabis users in a legally compliant fashion. Over the past 14 years, the Weedmaps marketplace has become the premier destination for cannabis consumers to discover and browse information regarding cannabis and cannabis products, permitting product discovery and order-ahead for pick-up or delivery by participating retailers. Weedmaps for Business is a set of eCommerce-enablement tools designed to help retailers and brands get the best out of the Weedmaps’ consumer experience, create labor efficiencies, and manage compliance needs.

WM Technology holds a strong belief in the power of cannabis and the importance of enabling safe, legal access to consumers worldwide. Since inception, WM Technology has worked tirelessly, not only to become the most comprehensive platform for consumers, but to build the software solutions that power businesses compliantly in the space, to advocate for legalization, social equity, and licensing in many jurisdictions, and to facilitate further learning through partnering with subject matter experts on providing detailed, accurate information about the plant.

Headquartered in Irvine, California, WM Technology supports remote work for all eligible employees. Visit us at www.weedmaps.com.

Contacts

Media Relations:
Travis Rexroad, Corporate Communications

press@weedmaps.com

Investor Relations:
investors@weedmaps.com

This post was originally published on this site





Source link

Continue Reading

Business Wire

Flora Growth Sets First Half 2022 Conference Call for August 15, 2022, at 4:30 p.m. ET

Published

on

By


FORT LAUDERDALE, Fla. & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, will host its first half 2022 earnings call via webcast on Monday, August 15, 2022, at 4:30 p.m. ET. The Company’s results will be reported in a press release prior to the call.

During the webcast, Flora management will deliver financial and operational results for the six months ended June 30, 2022, in addition to comments on the Company’s 2022 commercial operations, house of brands and life sciences strategies. Following the presentation, Flora will open the floor to analysts, media and investors in a Q&A format.

Live Audio Webcast Details

Date: Monday, August 15, 2022

Time: 4:30 p.m. Eastern time

Webcast Link: https://www.floragrowth.com/flgc-h1-2022-earnings-call/

The live webcast will be available online through the above participant link and will be archived and available on the Company’s website within approximately 24 hours. If any member of the investment community needs access to a phone dial-in, please email flora@cmwmedia.com and one will be provided.

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands delivering the most compelling customer experiences in the world, one community at a time. As the operator of one of the most extensive outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands, and life sciences divisions. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains ‘‘forward-looking statements,’’ as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward looking statements. Such forward-looking statements are subject to various risks and uncertainties, including those described under the section entitled “Risk Factors” in Flora’s Annual Report on Form 20-F filed with the SEC on May 9, 2022, as such factors may be updated from time to time in Flora’s periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora’s filings with the SEC. While forward-looking statements reflect Flora’s good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based only on information currently available to Flora (or to third parties making the forward-looking statements).

Contacts

Investor Relations:
Sean Mansouri

ir@floragrowth.com

Public Relations:
Cassandra Dowell

+1 (858) 221-8001

flora@cmwmedia.com

This post was originally published on this site



Source link

Continue Reading

Business Wire

Rapid Dose Therapeutics Announces Closing of First Tranche of Private Placement

Published

on

By


BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, today announced that it has closed on $230,000 in a first tranche of its previously announced (May 26, 2022) private placement financing (the “Financing”) for up to $5,000,000 of gross proceeds, consisting of up to 5,000 units (the “Units”) at a price of $1,000 per Unit. Each Unit consists of $1,000 principal amount of unsecured convertible notes (the “Notes”) and 100 common share purchase warrants of the Company (the “Warrants”).

On this first tranche closing, 230 Units were purchased; and accordingly, the Company issued $230,000 principal amount of Notes and 23,000 Warrants.

The Notes have a maturity date of 24 months from the closing date and bear interest from their date of issue at 10.0% per annum, payable quarterly in arrears. A further 2% per annum interest payment will be made annually in cash or in common shares of the Company (“Common Shares”) as determined by the Company. During the second year of the two-year term of the Notes, the Company may prepay all or any portion of each of the Notes with an early termination fee payable to each noteholder of 1% of the amount of the principal prepayment of the Note.

The Notes are convertible, at the option of the holders at any time prior to maturity, into Common Shares at a conversion price of $0.40 per Common Share. Each Warrant may be exercised for one Common Share at a price of $0.40 per Common Share for a term of 24 months from the closing date. All securities issued on the Financing are subject to a four month hold from the date of closing.

The Company intends to use the proceeds from the Financing to continue its research and development of oral thin films embedded with vaccines and mRNA as the active ingredients, to finance capital expansion projects for specific revenue streams, for working capital supporting revenue streams coming on line and costs and fees for the Financing.

No commissions were paid in connection with this first tranche closing; however, fees may be payable to authorized dealers or finders on subsequent closings and such commissions would consist of cash of 8% of the gross proceeds raised and broker warrants equal to 8% of such gross proceeds (the “Broker Warrants”). Each Broker Warrant would entitle the holder thereof to acquire one Common Share at a price of $0.40 per share for a term of 24 months from the closing date.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company revolutionizing drug delivery through innovation. The Company’s flagship product QuickStrip™ is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. For more information about the Company, visit www.rapid-dose.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS:

Certain information in this news release may contain forward-looking information within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “will”, “could”, “are planned to”, “are expected to” or the negative of these terms and similar expressions. Statements containing forward-looking information, including, without limitation, in respect of the delivery of equipment and products using the QuickStrip™ product delivery method, the generation of recurring revenues, the plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally, income tax and regulatory matters; the ability to implement its business strategies; competition; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that statements of forward-looking information, although considered reasonable by RDT management at the time of preparation, will prove to be accurate as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. Actual results and future events could differ materially from those anticipated in such forward-looking statements. Readers should not place undue reliance on forward-looking statements. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

RDT Investor Contact:
Mark Upsdell, CEO

mupsdell@rapid-dose.com
416-477-1052

Media Contact:
Dara Willis

dara@dwcomm.ca
416-836-9272

This post was originally published on this site



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media